Publications by authors named "Joy Q Jin"

Article Synopsis
  • Psoriasis affects about 3% of the US population and is linked to various sleep disturbances, which can increase risks of cardiovascular issues, metabolic disorders, and depression.
  • The study analyzed data from the National Health and Nutrition Examination Survey to investigate the relationship between psoriasis and sleep problems, controlling for demographics and health history.
  • Findings indicate that psoriasis is strongly related to sleep issues but not sleep duration, highlighting the importance of evaluating sleep quality for better management of psoriasis and its complications.
View Article and Find Full Text PDF

Background: The risk of developing cutaneous T cell lymphoma (CTCL) in patients using psoriasis biologics has not been well characterized. The goals of this review were to investigate the incidence of CTCL in patients with psoriasis receiving biologic therapy in clinical trials and psoriasis registries, and to review cases of CTCL and biologic use reported in scientific publications.

Methods: The US National Library of Medicine clinical trials database (clinicaltrials.

View Article and Find Full Text PDF

Prior studies have found associations between atopic dermatitis (AD) and comorbidities, including depression, obesity, asthma, and allergic rhinitis. Although observational studies often cannot establish robust causality between potential risk factors and AD, Mendelian randomization minimizes confounding when exploring causality by relying on random allelic assortment at birth. In this study, we systematically reviewed 30 Mendelian randomization studies in AD.

View Article and Find Full Text PDF
Article Synopsis
  • Topical medications are the most common treatment for psoriasis, but traditional options are often limited by short-term use and low effectiveness.
  • Tapinarof is a newly approved topical medication that works by targeting specific immune responses and improving skin barrier function, offering an alternative to steroids.
  • Clinical trials have shown that Tapinarof is effective for both immediate and long-term treatment of moderate-to-severe psoriasis, with good tolerability and prolonged effects after stopping the medication.
View Article and Find Full Text PDF

Background: Poor sleep quality occurs in patients with psoriasis at rates nearly twice that of the general population. Chronic sleep impairment is an independent risk factor for the development of cardiovascular disease. Here, we examine the association between sleep quantity and history of myocardial infarction in patients with psoriasis.

View Article and Find Full Text PDF

Introduction: In-person dermatology clinical research studies often face recruitment and participation challenges due to travel-, time-, and cost-associated barriers. Studies incorporating virtual/asynchronous formats can potentially enhance research subject participation and satisfaction, but few mobile health tools are available to enable remote study conduct. We developed SkinTracker, a patient-facing mobile app and researcher-facing web platform, that enables longitudinal collection of skin photos, patient reported outcomes, and biometric health and environmental data.

View Article and Find Full Text PDF

Recent basic science advances in psoriatic disease (PsD) were presented and discussed at the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2022 annual meeting. Topics included clinical applications of biomarkers, what the future of biomarkers for PsD may hold, the challenges of developing biomarker research to the point of clinical utility, advances in total-body positron emission tomography/computed tomography imaging, and emerging concepts from single-cell studies in PsD.

View Article and Find Full Text PDF

Background: Psoriasis patients with poor therapeutic response to multiple biologic agents are not well-characterized.

Objective: To describe the characteristics associated with development of multiple biologic failure (MBF) versus good clinical response (GR) to the first biologic.

Methods: This prospective cohort analysis evaluated patients in the multicenter CorEvitas Psoriasis Registry who initiated their first biologic between 2015 and 2020 and were followed for ≥24 months.

View Article and Find Full Text PDF

 This article characterizes the resources used by ophthalmology residency applicants when deciding where to apply, interview, and rank.  Cross-sectional, online survey.  All applicants to the University of California-San Francisco ophthalmology residency program during the 2019 to 2020 and 2020 to 2021 application cycles.

View Article and Find Full Text PDF

Introduction: Psoriasis is a chronic, immune-mediated skin condition with significant detriments to physical/mental health. While systemic therapies are available for the treatment of moderate-to-severe psoriasis, patients can experience therapeutic failure, loss of efficacy, or medical contraindications that require other therapeutic options.

Objective: With the recent approval of deucravacitinib, a first-in-class TYK2 small molecule inhibitor administered orally for psoriasis patients, we reviewed data from randomized controlled trials (RCTs) to synthesize its clinical utility.

View Article and Find Full Text PDF

Psoriasis vulgaris is a systemic, chronic inflammatory disease affecting 2-3% of the population. Recent advances in the understanding of the pathophysiology of psoriatic disease have facilitated the development of novel therapeutic options with improved safety and efficacy. This article is coauthored by a patient with a lifelong history of psoriasis who experienced multiple treatment failures.

View Article and Find Full Text PDF

Psoriasis (PSO) and psoriatic arthritis (PSA) are inflammatory diseases with complex genetic and environmental contributions. Although studies have identified environmental and clinical associations with PSO/PSA, causality is difficult to establish. Mendelian randomization (MR) employs the random assortment of genetic alleles at birth to evaluate the causal impact of exposures.

View Article and Find Full Text PDF

Background: This review's goals were to investigate apremilast's efficacy versus placebo in palmoplantar psoriasis (PP) and palmoplantar pustulosis (PPP), and apremilast's efficacy versus methotrexate in PP.

Methods: A literature search was conducted in PubMed, clinicaltrials.gov, and Embase in July 2022.

View Article and Find Full Text PDF

In this study, we examined the impact of diabetes mellitus (DM) disease duration on optical coherence tomography angiography (OCTA) parameters in diabetic patients without diabetic retinopathy (DR). A total of 1118 eyes from 1118 DM patients without DR were divided into three groups by DM duration: 0−5 years (short cohort; n = 571), 6−10 years (medium cohort; n = 306), and >10 years (long cohort; n = 241). Ultra-widefield fundus photography and nine OCTA parameters derived from the superficial retinal capillary plexus were analyzed.

View Article and Find Full Text PDF

Background: Hidradenitis suppurativa (HS) is an inflammatory skin disorder characterized by recurring painful and suppurating lesions, with the disease disproportionately affecting black populations in the United States. Ethnoracial representation in clinical trials is vital to ensuring results are generalizable. The purpose of this study is to examine whether ethnic or racial disparities exist in HS clinical trials.

View Article and Find Full Text PDF
Article Synopsis
  • Psoriasis (PSO) and psoriatic arthritis (PSA) are complex inflammatory diseases characterized by immune cell dysfunction, making early diagnosis and effective treatment challenging.
  • Single-cell RNA sequencing (scRNA-seq) has advanced our understanding by revealing distinct immune cell profiles and their interactions involved in PSO/PSA pathogenesis.
  • Analysis of recent studies suggests that while a small subset of immune cells can significantly influence disease outcomes, traditionally overlooked cell types also contribute, emphasizing the dynamic nature of immune responses and the potential for machine learning to enhance early diagnosis.
View Article and Find Full Text PDF

Psoriasis is a skin condition that affects over 100 million people worldwide, while multiple myeloma (MM) accounts for 10% of all hematologic malignancies in the US. There has been limited research on the intersection of psoriasis and MM, and clinicians often face difficult decisions in treating patients diagnosed with both conditions. For instance, the management of psoriasis with systemic immunotherapies in MM patients can be challenging because of concern about immunosuppression and possible worsening of MM.

View Article and Find Full Text PDF

Esophageal adenocarcinoma (EAC) accounts for the most esophageal cancer cases in the US, and is notoriously aggressive. This study examines the role of Sonic Hedgehog (SHh)/Gli signaling in the regulation of epithelial-mesenchymal transition (EMT), a process tied to invasion and metastasis, in EAC. Gli/EMT protein expression levels were examined by western blot in paired EAC patient tissues ( = 24) and cell lines (OE19, OE33).

View Article and Find Full Text PDF

The mechanism of Sonic Hedgehog (Shh) pathway activation in non-small cell lung cancer (NSCLC) is poorly described. Using an antibody against the Shh C-terminal domain, we found a small population of Shh-positive (Shh+) cells in NSCLC cells. The objective of this study was to characterize these Shh+ cells.

View Article and Find Full Text PDF

Adenocarcinoma is the most common type of lung cancer. Epithelial-mesenchymal transition (EMT) is required for tumor invasion/metastasis and the components that control this process are potential therapeutic targets. This study we examined the role of Gli in lung adenocarcinoma and whether its activation regulates metastasis through EMT in lung adenocarcinoma.

View Article and Find Full Text PDF

Background: Squamous cell carcinomas (SCC) account for approximately 30% of non-small cell lung cancer (NSCLC). Current staging methods do not adequately predict outcome for this disease. EMX2 is a homeo-domain containing transcription factor known to regulate a key developmental pathway.

View Article and Find Full Text PDF

Purpose: Novel molecular predictive biomarkers for chemotherapy have been screened and validated in non-small cell lung cancer (NSCLC). However, there was no report on the correlation of genome-wide DNA methylation with survival benefit from chemotherapy in NSCLC.

Methods: A sandwich enzyme-linked immunosorbent assay (ELISA) method was first established, optimized and validated.

View Article and Find Full Text PDF